Glycotreat
GlycoTreat develops glyco-immunotherapy with the mission to develop a cure for all humans and animals suffering from allergies. Utilizing our unique glycan-mediated immune pathway, we are redirecting the immune system to develop lifelong tolerance towards specific antigens. GlycoTreat’s scientific co-founder, Prof. Yvette van Kooyk, Molecular Cell Biology and Immunology at Amsterdam UMC, received the Spinoza Prize [the highest scientific award in the Netherlands] for her groundbreaking research.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Glycotreat
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
Showing 1 of 4 verified contacts
Top roles at Glycotreat
3 distinct titles indexed · top 3 shown.
- 1clinical research manager immunology
- 1program director of immunology
- 1research scientist immunology
Sign up to unlock all 4 contacts at Glycotreat
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Glycotreat
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.